Insulet Corporation Share Price & Technical Analysis
PODD · $153.8 (-0.69%)
Healthcare / Medical Devices
$153.8
-0.69%
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain …
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-11% return in May, 6% avg return in past 3 year May month.
-58% return in 2026, 11% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -10% | -4% | -14% | -18% | -11% | – | – | – | – | – | – | – | -58% |
| 25 | 7% | -1% | -4% | -3% | 29% | -3% | -7% | 19% | -9% | 1% | 4% | -12% | 20% |
| 24 | -11% | -15% | 5% | 0% | 3% | 14% | -4% | 4% | 15% | -1% | 16% | -2% | 24% |
| 23 | -4% | -4% | 16% | 0% | -14% | 5% | -4% | -30% | -17% | -19% | 43% | 15% | -13% |
| 22 | -6% | 6% | 2% | -10% | -11% | 1% | 14% | 4% | -10% | 12% | 15% | -3% | 15% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$11.01B
P/E ratio
37.04
52W high
$354.9
52W low
$145.6
Volume
12,22,283
Beta
1.20
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Insulet Corporation share price today?
- Insulet Corporation (PODD) last traded around $153.8 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does PODD have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PODD. Download the app for real-time alerts.
- How can I analyze Insulet Corporation stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.